{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:08:35Z","timestamp":1788444515688,"version":"build-2803163510"},"reference-count":16,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2024,4,15]]},"DOI":"10.1080\/10428194.2024.2310141","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T13:00:03Z","timestamp":1711976403000},"page":"647-652","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Phase 1\/2 multicenter trial of acalabrutinib in Chinese patients with relapsed\/refractory mantle cell lymphoma"],"prefix":"10.1080","volume":"65","author":[{"given":"Yuqin","family":"Song","sequence":"first","affiliation":[{"name":"Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ke","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking University Third Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Hematology, the First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Cancer Institute and Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yao","sequence":"additional","affiliation":[{"name":"AstraZeneca, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xia","sequence":"additional","affiliation":[{"name":"AstraZeneca, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiu","family":"Wang","sequence":"additional","affiliation":[{"name":"AstraZeneca, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqiong","family":"Lai","sequence":"additional","affiliation":[{"name":"AstraZeneca, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[{"name":"AstraZeneca, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Lymphoma, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26523"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0785-7"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-6-77"},{"issue":"4","key":"e_1_3_5_5_1","first-page":"iv141","article-title":"The relative frequencies of lymphoma subtypes in China: a nationwide study of 10002 cases by the Chinese lymphoma study group [abstract 169]","volume":"22","author":"Li X","year":"2011","unstructured":"Li X, Li G, Gao Z, et\u00a0al. The relative frequencies of lymphoma subtypes in China: a nationwide study of 10002 cases by the Chinese lymphoma study group [abstract 169]. Ann Oncol. 2011;22(Suppl 4):iv141.","journal-title":"Ann Oncol"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP7YLTQPUSDQ5C"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2011.05.001"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306220"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)33108-2"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30262-2"},{"key":"e_1_3_5_11_1","volume-title":"Calquence [package insert]","year":"2022","unstructured":"Calquence [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals; 2022 August 2022."},{"issue":"25","key":"e_1_3_5_12_1","first-page":"JCO2300838","article-title":"ASCEND: phase III, randomized trial of acalabrutinib versus idelalisib plus rituximab or bendamustine plus rituximab in relapsed or refractory chronic lymphocytic leukemia","volume":"38","year":"2020","unstructured":"Ghia P, Pluta A, Wach M, et al. ASCEND: phase III, randomized trial of acalabrutinib versus idelalisib plus rituximab or bendamustine plus rituximab in relapsed or refractory chronic lymphocytic leukemia. J Clin Oncol. 2020;38(25):JCO2300838\u20132861.","journal-title":"J Clin Oncol"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_3_5_14_1","volume-title":"Annual Meeting and Exposition of the American Society of Hematology","author":"Zhu J","year":"2022","unstructured":"Zhu J, Song Y, Li J, et\u00a0al. editors. Pharmacokinetics, safety, and efficacy of acalabrutinib in chinese patients with relapsed\/refractory mantle cell lymphoma and other B-cell malignancies: an open-label, multicenter phase 1\/2 trial [poster 2892]. Annual Meeting and Exposition of the American Society of Hematology; 2022 10-13 December 2022; New Orleans, LA, USA."},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-635326"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004074"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021014162"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2024.2310141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T13:58:13Z","timestamp":1714139893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2024.2310141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,4,15]]}},"alternative-id":["10.1080\/10428194.2024.2310141"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2024.2310141","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-07-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}